Health
Bioengineered ankyrin compounds show high in vitro activity against SARS-CoV-2 mutants – News-Medical.Net
A new study describes the use of DARPin (designed ankyrin repeat proteins) therapeutic agents, each of which contains three different DARPin domains within the…
The ongoing coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resisted successful containment by most non-pharmaceutical measures. Vaccination and natural immunity appear to be the only definitive methods to attain population immunity, and thus lead to a return to global normalcy. However, effective therapies continue to be sought after to reduce the high mortality rate from severe COVID-19 disease.
A new preprint on the bioRxiv*…
-
Business21 hours ago3 ASX ETFs to buy now for explosive long-term growth
-
Noosa News19 hours agoUp $136k in a year: Brisbane house price surges as Qld booms
-
Noosa News14 hours agoDicky Bill salad greens farms enter administration with 180 job cuts just before Christmas
-
General22 hours agoDeath toll in Hong Kong blaze rises to 146 after more bodies found